Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Le système histaminergique : une cible pour de nouveaux traitements des déficits cognitifs

Mouhammad Motawaj, Aude Burban, Elisabeth Davenas, Florence Gbahou, Raphaël Faucard, Séverine Morisset, Jean-Michel Arrang

Therapie, 65 5 (2010) 415-422

Publié en ligne : 2010-12-13

DOI: https://doi.org/10.2515/therapie/2010058

Citations de cet article :

Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications

Nagaraju Bandaru, Sarad Pawar Naik Bukke, Veera Mani Deepika Pedapati, Gurugubelli Sowjanaya, Vangmai Swaroopa Suggu, Swathi Nalla, Prashik Bhimrao Dudhe, Joseph Obiezu Chukwujekwu Ezeonwumelu, Abdullateef Isiaka Alagbonsi and Hope Onohuean
Drugs and Drug Candidates 4 (2) 22 (2025)
https://doi.org/10.3390/ddc4020022

Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis

Chun-Hung Su, Kuang-Hua Huang, Yih Yang, Shuo-Yan Gau, Ning-Jen Chung, Po-Tseng Wu, Tung-Han Tsai and Chien-Ying Lee
The Journal of Allergy and Clinical Immunology: In Practice 12 (8) 2155 (2024)
https://doi.org/10.1016/j.jaip.2024.05.027

The Usage of Histamine Type 1 Receptor Antagonist and Risk of Dementia in the Elderly: A Nationwide Cohort Study

Chuan-Chi Yang, Wu-Chien Chien, Chi-Hsiang Chung, Chung-Yu Lai and Nian-Sheng Tzeng
Frontiers in Aging Neuroscience 14 (2022)
https://doi.org/10.3389/fnagi.2022.811494

Therapeutics of Neurotransmitters in Alzheimer’s Disease

Ramesh Kandimalla and P. Hemachandra Reddy
Journal of Alzheimer's Disease 57 (4) 1049 (2017)
https://doi.org/10.3233/JAD-161118

Therapeutic strategies for Alzheimer's disease in clinical trials

Justyna Godyń, Jakub Jończyk, Dawid Panek and Barbara Malawska
Pharmacological Reports 68 (1) 127 (2016)
https://doi.org/10.1016/j.pharep.2015.07.006

Therapeutics of Alzheimer's disease: Past, present and future

R. Anand, Kiran Dip Gill and Abbas Ali Mahdi
Neuropharmacology 76 27 (2014)
https://doi.org/10.1016/j.neuropharm.2013.07.004

The Neglected Role of Histamine in Alzheimer’s Disease

Fatemeh Naddafi and Abbas Mirshafiey
American Journal of Alzheimer's Disease & Other Dementias® 28 (4) 327 (2013)
https://doi.org/10.1177/1533317513488925

Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care

Ludwig Trillo, Devsmita Das, Wayne Hsieh, et al.
Neuroscience & Biobehavioral Reviews 37 (8) 1363 (2013)
https://doi.org/10.1016/j.neubiorev.2013.05.008